InSite Vision (ISV) Initiates Confirmatory Phase 3 Clinical Study of BromSite™ for the Reduction of Inflammation and Pain After Cataract Surgery
5/10/2013 10:05:17 AM
More...
|
InSite Vision (ISV) Reports First Quarter 2013 Financial Results
5/8/2013 7:44:47 AM
More...
|
InSite Vision (ISV) to Present Five Scientific Posters at 2013 Association for Research in Vision & Ophthalmology Meeting
4/29/2013 6:47:48 AM
More...
|
InSite Vision (ISV) to Report First Quarter 2013 Financial Results on May 7, 2013
4/29/2013 6:45:47 AM
More...
|
InSite Vision (ISV) Announces Sale of Besivance® Royalty for $16 Million
4/2/2013 8:19:38 AM
More...
|
Gholam A. Peyman, M.D., Joins InSite Vision (ISV)’s Scientific Advisory Board
3/27/2013 7:04:26 AM
More...
|
InSite Vision (ISV) Wins Appeal of Patent Interference Litigation Against the University of California, San Francisco (UCSF)
3/26/2013 11:12:52 AM
More...
|
InSite Vision (ISV) Completes DOUBle Phase 3 Clinical Study of AzaSite Plus™ and DexaSite™ for the Treatment of Blepharitis
3/25/2013 9:25:41 AM
More...
|
InSite Vision (ISV) Announces Positive Phase 3 Results for BromSite™
3/19/2013 7:14:45 AM
More...
|
InSite Vision (ISV) to Present at the 25th Annual ROTH Conference
3/11/2013 6:44:51 AM
More...
|
|